title: [A-TOP research group/JOINT-02].
authors.affiliation: Department of Obstetrics and Gynecology, Tokyo Women's Medical University.
authors.forename: Tatsuhiko
authors.initials: T
authors.lastname: Kuroda
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ohta
authors.forename: Masataka
authors.initials: M
authors.lastname: Shiraki
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Miyakawa
authors.forename: Takayuki
authors.initials: T
authors.lastname: Hosoi
authors.forename: Toshitaka
authors.initials: T
authors.lastname: Nakamura
authors.forename: Masao
authors.initials: M
authors.lastname: Fukunaga
authors.forename: Hajime
authors.initials: H
authors.lastname: Orimo
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002116:Calcitonin / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007564:Japan; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D014944:World Health Organization
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D002762:Cholecalciferol; D002116:Calcitonin